Gabapentinoid Use Continues to Climb

(MedPage Today) -- Gabapentinoid users increased from 4.0% in 2015 to 4.7% in 2021, Medical Expenditure Panel Survey (MEPS) data showed. Moreover, gabapentinoids -- which includes gabapentin and pregabalin -- continued to be used for chronic...

https://www.medpagetoday.com/neurology/generalneurology/108370

Source: MedPage Today Neurology - January 22, 2024 Category: Neurology Source Type: news